@article{405efbe55828433b8c8b6d838a5099fc,
title = "Intravenous azacitidine for MDS",
author = "Gore, {Steven D.}",
note = "Funding Information: The authors would like to thank Alberto Garcia, Gary Hubbard, Ken St. Hilaire, Keith Penney, and Sal Birtola for their dedicated support of the DISI laboratory. Also, thanks to Drs. W. Ethan Eagle and Kan Zha for helpful discussions and for reviewing this paper. The work was performed at the Combustion Research Facility, Sandia National Laboratories, Livermore, CA. Financial support was provided by the U.S. Department of Energy, Office of Vehicle Technologies. Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. Dr. Zongjie Hu's visit was financially supported by China Scholarship Council, and National Natural Science Foundation of China (Project no. 51106113 ).",
year = "2007",
month = mar,
language = "English (US)",
volume = "5",
pages = "234",
journal = "Clinical Advances in Hematology and Oncology",
issn = "1543-0790",
publisher = "Millennium Medical Publishing, Inc.",
number = "3",
}